GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 827 filers reported holding GLAXOSMITHKLINE PLC in Q2 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $438,000 | +21.7% | 9,974 | +22.3% | 0.04% | +42.3% |
Q1 2022 | $360,000 | -17.4% | 8,156 | -16.4% | 0.03% | +4.0% |
Q4 2021 | $436,000 | +19.5% | 9,760 | +3.5% | 0.02% | +13.6% |
Q3 2021 | $365,000 | +15.1% | 9,429 | +19.9% | 0.02% | +10.0% |
Q2 2021 | $317,000 | +41.5% | 7,864 | +27.7% | 0.02% | +25.0% |
Q1 2021 | $224,000 | -28.2% | 6,159 | -26.4% | 0.02% | -30.4% |
Q4 2020 | $312,000 | -2.2% | 8,373 | +0.1% | 0.02% | -17.9% |
Q3 2020 | $319,000 | +14.3% | 8,361 | +23.6% | 0.03% | +3.7% |
Q2 2020 | $279,000 | -37.9% | 6,767 | -42.1% | 0.03% | -44.9% |
Q1 2020 | $449,000 | -17.5% | 11,681 | +1.7% | 0.05% | -9.3% |
Q4 2019 | $544,000 | +114.2% | 11,482 | +94.5% | 0.05% | -14.3% |
Q3 2019 | $254,000 | -36.7% | 5,903 | -41.1% | 0.06% | +53.7% |
Q2 2019 | $401,000 | +63.7% | 10,020 | +72.5% | 0.04% | +64.0% |
Q1 2019 | $245,000 | +18.4% | 5,810 | +8.2% | 0.02% | 0.0% |
Q4 2018 | $207,000 | +16.3% | 5,368 | +20.9% | 0.02% | -50.0% |
Q3 2018 | $178,000 | – | 4,439 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |